 | • レポートコード：MRC2-11QY11551 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は嚢虫症治療のグローバル市場について調査・分析したレポートです。種類別（プラジカンテル、アルベンダゾール）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別嚢虫症治療の競争状況、市場シェア ・世界の嚢虫症治療市場：種類別市場規模 2015年-2020年（プラジカンテル、アルベンダゾール） ・世界の嚢虫症治療市場：種類別市場規模予測 2021年-2026年（プラジカンテル、アルベンダゾール） ・世界の嚢虫症治療市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界の嚢虫症治療市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米の嚢虫症治療市場分析：米国、カナダ ・ヨーロッパの嚢虫症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの嚢虫症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の嚢虫症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの嚢虫症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Amedra Pharmaceuticals、Bayer、Klarsehen India、Ranbaxy、Salius、Cipla、Pharmaco-Kinesis、Bonaide、Taj Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cysticercosis or Taeniasis is an infection caused primarily due to tapeworms.
Globally, increasing government initiative to eradicate Cysticercosis, rise in the in incidences of Cysticercosis in developing regions, and increasing awareness among people for Cysticercosis are the prime growth drivers of global cysticercosis treatment market.
Market Analysis and Insights: Global Cysticercosis Treatment Market
The global Cysticercosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cysticercosis Treatment Scope and Market Size
Cysticercosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cysticercosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Amedra Pharmaceuticals
Bayer
Klarsehen India
Ranbaxy
Salius
Cipla
Pharmaco-Kinesis
Bonaide
Taj Pharmaceuticals
Market segment by Type, the product can be split into
Praziquantel
Albendazole
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cysticercosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Cysticercosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Praziquantel
1.4.3 Albendazole
1.5 Market by Application
1.5.1 Global Cysticercosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cysticercosis Treatment Market Perspective (2015-2026)
2.2 Global Cysticercosis Treatment Growth Trends by Regions
2.2.1 Cysticercosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cysticercosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Cysticercosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cysticercosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Cysticercosis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cysticercosis Treatment Players by Market Size
3.1.1 Global Top Cysticercosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Cysticercosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Cysticercosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cysticercosis Treatment Market Concentration Ratio
3.2.1 Global Cysticercosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cysticercosis Treatment Revenue in 2019
3.3 Cysticercosis Treatment Key Players Head office and Area Served
3.4 Key Players Cysticercosis Treatment Product Solution and Service
3.5 Date of Enter into Cysticercosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cysticercosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Cysticercosis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cysticercosis Treatment Market Size by Application (2015-2020)
5.2 Global Cysticercosis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cysticercosis Treatment Market Size (2015-2020)
6.2 Cysticercosis Treatment Key Players in North America (2019-2020)
6.3 North America Cysticercosis Treatment Market Size by Type (2015-2020)
6.4 North America Cysticercosis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cysticercosis Treatment Market Size (2015-2020)
7.2 Cysticercosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Cysticercosis Treatment Market Size by Type (2015-2020)
7.4 Europe Cysticercosis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Cysticercosis Treatment Market Size (2015-2020)
8.2 Cysticercosis Treatment Key Players in China (2019-2020)
8.3 China Cysticercosis Treatment Market Size by Type (2015-2020)
8.4 China Cysticercosis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cysticercosis Treatment Market Size (2015-2020)
9.2 Cysticercosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Cysticercosis Treatment Market Size by Type (2015-2020)
9.4 Japan Cysticercosis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cysticercosis Treatment Market Size (2015-2020)
10.2 Cysticercosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cysticercosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Cysticercosis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Cysticercosis Treatment Market Size (2015-2020)
11.2 Cysticercosis Treatment Key Players in India (2019-2020)
11.3 India Cysticercosis Treatment Market Size by Type (2015-2020)
11.4 India Cysticercosis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cysticercosis Treatment Market Size (2015-2020)
12.2 Cysticercosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Cysticercosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Cysticercosis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Cysticercosis Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Cysticercosis Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Amedra Pharmaceuticals
13.2.1 Amedra Pharmaceuticals Company Details
13.2.2 Amedra Pharmaceuticals Business Overview
13.2.3 Amedra Pharmaceuticals Cysticercosis Treatment Introduction
13.2.4 Amedra Pharmaceuticals Revenue in Cysticercosis Treatment Business (2015-2020)
13.2.5 Amedra Pharmaceuticals Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Cysticercosis Treatment Introduction
13.3.4 Bayer Revenue in Cysticercosis Treatment Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Klarsehen India
13.4.1 Klarsehen India Company Details
13.4.2 Klarsehen India Business Overview
13.4.3 Klarsehen India Cysticercosis Treatment Introduction
13.4.4 Klarsehen India Revenue in Cysticercosis Treatment Business (2015-2020)
13.4.5 Klarsehen India Recent Development
13.5 Ranbaxy
13.5.1 Ranbaxy Company Details
13.5.2 Ranbaxy Business Overview
13.5.3 Ranbaxy Cysticercosis Treatment Introduction
13.5.4 Ranbaxy Revenue in Cysticercosis Treatment Business (2015-2020)
13.5.5 Ranbaxy Recent Development
13.6 Salius
13.6.1 Salius Company Details
13.6.2 Salius Business Overview
13.6.3 Salius Cysticercosis Treatment Introduction
13.6.4 Salius Revenue in Cysticercosis Treatment Business (2015-2020)
13.6.5 Salius Recent Development
13.7 Cipla
13.7.1 Cipla Company Details
13.7.2 Cipla Business Overview
13.7.3 Cipla Cysticercosis Treatment Introduction
13.7.4 Cipla Revenue in Cysticercosis Treatment Business (2015-2020)
13.7.5 Cipla Recent Development
13.8 Pharmaco-Kinesis
13.8.1 Pharmaco-Kinesis Company Details
13.8.2 Pharmaco-Kinesis Business Overview
13.8.3 Pharmaco-Kinesis Cysticercosis Treatment Introduction
13.8.4 Pharmaco-Kinesis Revenue in Cysticercosis Treatment Business (2015-2020)
13.8.5 Pharmaco-Kinesis Recent Development
13.9 Bonaide
13.9.1 Bonaide Company Details
13.9.2 Bonaide Business Overview
13.9.3 Bonaide Cysticercosis Treatment Introduction
13.9.4 Bonaide Revenue in Cysticercosis Treatment Business (2015-2020)
13.9.5 Bonaide Recent Development
13.10 Taj Pharmaceuticals
13.10.1 Taj Pharmaceuticals Company Details
13.10.2 Taj Pharmaceuticals Business Overview
13.10.3 Taj Pharmaceuticals Cysticercosis Treatment Introduction
13.10.4 Taj Pharmaceuticals Revenue in Cysticercosis Treatment Business (2015-2020)
13.10.5 Taj Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cysticercosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Cysticercosis Treatment Revenue
Table 3. Ranking of Global Top Cysticercosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cysticercosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Praziquantel
Table 6. Key Players of Albendazole
Table 7. Global Cysticercosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cysticercosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cysticercosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cysticercosis Treatment Market Share by Regions (2015-2020)
Table 11. Global Cysticercosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cysticercosis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cysticercosis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Cysticercosis Treatment Players
Table 18. Global Cysticercosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Cysticercosis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Cysticercosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cysticercosis Treatment as of 2019)
Table 21. Global Cysticercosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cysticercosis Treatment Product Solution and Service
Table 24. Date of Enter into Cysticercosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Cysticercosis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Cysticercosis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Cysticercosis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Cysticercosis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Cysticercosis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Cysticercosis Treatment Market Share (2019-2020)
Table 34. North America Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Cysticercosis Treatment Market Share by Type (2015-2020)
Table 36. North America Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Cysticercosis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Cysticercosis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Cysticercosis Treatment Market Share (2019-2020)
Table 40. Europe Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Cysticercosis Treatment Market Share by Type (2015-2020)
Table 42. Europe Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Cysticercosis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Cysticercosis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Cysticercosis Treatment Market Share (2019-2020)
Table 46. China Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Cysticercosis Treatment Market Share by Type (2015-2020)
Table 48. China Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Cysticercosis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Cysticercosis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Cysticercosis Treatment Market Share (2019-2020)
Table 52. Japan Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Cysticercosis Treatment Market Share by Type (2015-2020)
Table 54. Japan Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Cysticercosis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Cysticercosis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Cysticercosis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Cysticercosis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Cysticercosis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Cysticercosis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Cysticercosis Treatment Market Share (2019-2020)
Table 64. India Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Cysticercosis Treatment Market Share by Type (2015-2020)
Table 66. India Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Cysticercosis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Cysticercosis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Cysticercosis Treatment Market Share (2019-2020)
Table 70. Central & South America Cysticercosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Cysticercosis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Cysticercosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Cysticercosis Treatment Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. Amedra Pharmaceuticals Company Details
Table 80. Amedra Pharmaceuticals Business Overview
Table 81. Amedra Pharmaceuticals Product
Table 82. Amedra Pharmaceuticals Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 83. Amedra Pharmaceuticals Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Product
Table 87. Bayer Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 88. Bayer Recent Development
Table 89. Klarsehen India Company Details
Table 90. Klarsehen India Business Overview
Table 91. Klarsehen India Product
Table 92. Klarsehen India Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 93. Klarsehen India Recent Development
Table 94. Ranbaxy Company Details
Table 95. Ranbaxy Business Overview
Table 96. Ranbaxy Product
Table 97. Ranbaxy Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 98. Ranbaxy Recent Development
Table 99. Salius Company Details
Table 100. Salius Business Overview
Table 101. Salius Product
Table 102. Salius Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 103. Salius Recent Development
Table 104. Cipla Company Details
Table 105. Cipla Business Overview
Table 106. Cipla Product
Table 107. Cipla Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 108. Cipla Recent Development
Table 109. Pharmaco-Kinesis Business Overview
Table 110. Pharmaco-Kinesis Product
Table 111. Pharmaco-Kinesis Company Details
Table 112. Pharmaco-Kinesis Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 113. Pharmaco-Kinesis Recent Development
Table 114. Bonaide Company Details
Table 115. Bonaide Business Overview
Table 116. Bonaide Product
Table 117. Bonaide Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 118. Bonaide Recent Development
Table 119. Taj Pharmaceuticals Company Details
Table 120. Taj Pharmaceuticals Business Overview
Table 121. Taj Pharmaceuticals Product
Table 122. Taj Pharmaceuticals Revenue in Cysticercosis Treatment Business (2015-2020) (Million US$)
Table 123. Taj Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cysticercosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Praziquantel Features
Figure 3. Albendazole Features
Figure 4. Global Cysticercosis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Others Case Studies
Figure 7. Cysticercosis Treatment Report Years Considered
Figure 8. Global Cysticercosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Cysticercosis Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Cysticercosis Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Cysticercosis Treatment Market Share by Players in 2019
Figure 13. Global Top Cysticercosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cysticercosis Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Cysticercosis Treatment Revenue in 2019
Figure 15. North America Cysticercosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Cysticercosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Cysticercosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Cysticercosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Cysticercosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Cysticercosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Cysticercosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…- ディンプルプラスティ治療の世界市場（～2026年） Dimpleplasty, is a minimally invasive procedure used to create dimples in the face, most commonly within the cheeks. Dimple surgery is performed with incisions in the mouth behind the area in the cheek where the dimples are created. A temporary self-absorbing suture is used to create the dimple with…
- 第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
- 腹水治療の世界市場（～2026年） Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. North America and Europe together account for largest market share in the overall ascites treatment market. Highly deve…
- 聴神経鞘腫治療の世界市場（～2026年） Market Analysis and Insights: Global Acoustic Neurinoma Treatment Market The global Acoustic Neurinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acoustic Neurinoma Treatment Scope and Market Size Acoust…